Astrocytoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Here we show that mutation of the RGD sequence to RGE in the human P2Y(2)R expressed in 1321N1 astrocytoma cells completely prevented UTP-induced chemotaxis as well as activation of G(o), Rac, and Vav2, a guanine nucleotide exchange factor for Rac.
|
16186116 |
2005 |
Childhood Astrocytoma
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Here we show that mutation of the RGD sequence to RGE in the human P2Y(2)R expressed in 1321N1 astrocytoma cells completely prevented UTP-induced chemotaxis as well as activation of G(o), Rac, and Vav2, a guanine nucleotide exchange factor for Rac.
|
16186116 |
2005 |
Tumor Cell Invasion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Given the regulatory role of Vav2, the function of Nek3 in PRL-mediated motility and invasion was examined.
|
17297458 |
2007 |
Squamous cell carcinoma
|
0.010 |
Biomarker
|
disease |
LHGDN |
Persistent activation of Rac1 in squamous carcinomas of the head and neck: evidence for an EGFR/Vav2 signaling axis involved in cell invasion.
|
17234718 |
2007 |
Narcolepsy
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Genome-wide association database developed in the Japanese Integrated Database Project.
|
19629137 |
2009 |
Multiple Sclerosis
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.
|
20598377 |
2010 |
Multiple Sclerosis
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Nevertheless, we found suggestive evidence for an association of MS with variants in two new genes, the VAV2 gene and the gene for ZNF433.
|
20598377 |
2010 |
Multiple Sclerosis
|
0.110 |
GeneticVariation
|
disease |
GWASDB |
Evidence for VAV2 and ZNF433 as susceptibility genes for multiple sclerosis.
|
20598377 |
2010 |
Glaucoma
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In addition, a genome-wide association study screening glaucoma susceptibility loci using single nucleotide polymorphisms analysis identified VAV2 and VAV3 as candidates for associated genes in Japanese open-angle glaucoma patients.
|
20140222 |
2010 |
Glaucoma, Primary Open Angle
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
The entire NTF4 gene and the POAG-associated SNPs rs2156323 (VAV2) and rs2801219 (VAV3) and their flanking regions were screened by resequencing in a clinically well-characterized cohort of 537 subjects that included cases of POAG (n = 141), PACG (n = 111), and ethnically matched normal controls (n = 285).
|
20463313 |
2010 |
Intraocular pressure disorder
|
0.010 |
Biomarker
|
disease |
BEFREE |
Vav2/Vav3-deficient mice, and to a lesser degree Vav2-deficient mice, show early onset of iridocorneal angle changes and elevated intraocular pressure, with subsequent selective loss of retinal ganglion cells and optic nerve head cupping, which are the hallmarks of glaucoma.
|
20140222 |
2010 |
Tumor Cell Invasion
|
0.040 |
Biomarker
|
phenotype |
BEFREE |
Expression of constitutively active Vav2 and RhoA in cells depleted for RIAM partially rescued their invasion, indicating that Vav2 and RhoA mediate RIAM function.
|
21454517 |
2011 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
New evidence suggests that the exchange factors Vav2 and Vav3 play synergistic roles in breast cancer by sustaining tumor growth, neoangiogenesis, and metastasis.
|
23033535 |
2012 |
Malignant neoplasm of breast
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Microarray analyses revealed that Vav2 and Vav3 controlled a vast transcriptional program in breast cancer cells through mechanisms that were shared between the two proteins, isoform-specific or synergistic.
|
23033540 |
2012 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
New evidence suggests that the exchange factors Vav2 and Vav3 play synergistic roles in breast cancer by sustaining tumor growth, neoangiogenesis, and metastasis.
|
23033535 |
2012 |
Breast Carcinoma
|
0.060 |
AlteredExpression
|
disease |
BEFREE |
Microarray analyses revealed that Vav2 and Vav3 controlled a vast transcriptional program in breast cancer cells through mechanisms that were shared between the two proteins, isoform-specific or synergistic.
|
23033540 |
2012 |
Hypertensive disease
|
0.010 |
GeneticVariation
|
group |
BEFREE |
The study objectives were to analyse the relationship of TOD to blood pressure, size of retinal arteries and veins, oxidative stress and different polymorphisms in the VAV-2 and VAV-3 genes in participants with hypertension.
|
24699462 |
2014 |
Malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Since VAV2 serves as a GEF for the small Rho GTPase Rac1, a key player in cell motility and adhesion, we explored the vimentin-VAV2 pathway as a potential novel regulator of lung cancer cell motility.
|
24858039 |
2015 |
Carcinoma of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Since VAV2 serves as a GEF for the small Rho GTPase Rac1, a key player in cell motility and adhesion, we explored the vimentin-VAV2 pathway as a potential novel regulator of lung cancer cell motility.
|
24858039 |
2015 |
Primary malignant neoplasm of lung
|
0.010 |
Biomarker
|
disease |
BEFREE |
Since VAV2 serves as a GEF for the small Rho GTPase Rac1, a key player in cell motility and adhesion, we explored the vimentin-VAV2 pathway as a potential novel regulator of lung cancer cell motility.
|
24858039 |
2015 |
Hematocrit procedure
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Hemoglobin measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
The Allelic Landscape of Human Blood Cell Trait Variation and Links to Common Complex Disease.
|
27863252 |
2016 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
These results indicate that MST3 interacts with VAV2 to activate Rac1 and promote the tumorigenicity of breast cancer.
|
26910843 |
2016 |
Breast Carcinoma
|
0.060 |
Biomarker
|
disease |
BEFREE |
These results indicate that MST3 interacts with VAV2 to activate Rac1 and promote the tumorigenicity of breast cancer.
|
26910843 |
2016 |
Malignant neoplasm of breast
|
0.060 |
Biomarker
|
disease |
BEFREE |
Finally, we confirmed that a dual targeting strategy is a viable and efficient therapeutic approach to hinder the metastasis of breast cancer in xenograft models, showcasing the important need for further clinical evaluation of this regimen to impede the spread of disease and improve patient survival.<b>Implications:</b> This study provides new insight into the therapeutic benefit of combining NEDD9 depletion with ROCK inhibition to reduce tumor cell dissemination and discovers a new regulatory role of NEDD9 in the modulation of VAV2-dependent activation of Rac1 and actin polymerization.<i></i>.
|
28235899 |
2017 |